Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

Jordi Navarro, José Ramón Santos, Ana Silva, Joaquin Burgos, Vicenç Falcó, Esteban Ribera, Arkaitz Imaz, Adrian Curran

Research output: Contribution to journalArticleResearch

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus'. Together they form a unique fingerprint.

Medicine & Life Sciences